Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beer

Showing results (781-790 of 888) with videos related to

Pageof 89
Sort By:
Prostate Cancer and Prostatic Diseases|January 25, 2017
Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAILA H Bryce, J J Alumkal, A Armstrong, et al.
Berliner Und Munchener Tierarztliche Wochenschrift|August 21, 2008
Bluetongue control--a new challenge for EuropeBirgit Makoschey, M Beer, S Zientara, et al.
Investigational New Drugs|November 29, 2014
A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancerJoshi J Alumkal, Rachel Slottke, Jacob Schwartzman, et al.
Integrative Cancer Therapies|April 7, 2022
Quality of Life of Prostate Cancer Survivors Participating in a Remotely Delivered Web-Based Behavioral Intervention Pilot Randomized TrialCrystal S Langlais, Yea-Hung Chen, Erin L Van Blarigan, et al.
Clinical Genitourinary Cancer|December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancerKevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
JAMA Oncology|March 10, 2018
Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical TrialDana E Rathkopf, Tomasz M Beer, Yohann Loriot, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2022
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPERAnthony M Joshua, Andrew Armstrong, Megan Crumbaker, et al.
The British Journal of Dermatology|December 20, 2018
Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvementM Doerschner, A Pekar-Lukacs, O Messerli-Odermatt, et al.
Journal of Oncology Practice|August 15, 2013
Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measureKaren A Autio, Antonia V Bennett, Xiaoyu Jia, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 19, 2018
A cluster of two human cases of tick-borne encephalitis (TBE) transmitted by unpasteurised goat milk and cheese in Germany, May 2016S O Brockmann, R Oehme, T Buckenmaier, et al.
Pageof 89

Showing results (781-790 of 888) with videos related to

Sort By:
Pageof 89
Prostate Cancer and Prostatic Diseases|January 25, 2017
Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAILA H Bryce, J J Alumkal, A Armstrong, et al.
Berliner Und Munchener Tierarztliche Wochenschrift|August 21, 2008
Bluetongue control--a new challenge for EuropeBirgit Makoschey, M Beer, S Zientara, et al.
Investigational New Drugs|November 29, 2014
A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancerJoshi J Alumkal, Rachel Slottke, Jacob Schwartzman, et al.
Integrative Cancer Therapies|April 7, 2022
Quality of Life of Prostate Cancer Survivors Participating in a Remotely Delivered Web-Based Behavioral Intervention Pilot Randomized TrialCrystal S Langlais, Yea-Hung Chen, Erin L Van Blarigan, et al.
Clinical Genitourinary Cancer|December 3, 2014
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancerKevin D Courtney, Judith B Manola, Aymen A Elfiky, et al.
JAMA Oncology|March 10, 2018
Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical TrialDana E Rathkopf, Tomasz M Beer, Yohann Loriot, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2022
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPERAnthony M Joshua, Andrew Armstrong, Megan Crumbaker, et al.
The British Journal of Dermatology|December 20, 2018
Interferon alfa-2a maintenance after salvage autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvementM Doerschner, A Pekar-Lukacs, O Messerli-Odermatt, et al.
Journal of Oncology Practice|August 15, 2013
Prevalence of pain and analgesic use in men with metastatic prostate cancer using a patient-reported outcome measureKaren A Autio, Antonia V Bennett, Xiaoyu Jia, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 19, 2018
A cluster of two human cases of tick-borne encephalitis (TBE) transmitted by unpasteurised goat milk and cheese in Germany, May 2016S O Brockmann, R Oehme, T Buckenmaier, et al.
Pageof 89